1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017


DelveInsight’s Report, “Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Acid Indigestion / Heartburn/ Pyrosis Report is to understand the market and pipeline status of the drugs around the Acid Indigestion / Heartburn/ Pyrosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Acid Indigestion / Heartburn/ Pyrosis. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Acid Indigestion / Heartburn/ Pyrosis.
- A review of the marketed products under prescription for Acid Indigestion / Heartburn/ Pyrosis, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Acid Indigestion / Heartburn/ Pyrosis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Acid Indigestion / Heartburn/ Pyrosis drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Acid Indigestion / Heartburn/ Pyrosis drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Acid Indigestion / Heartburn/ Pyrosis drugs.
- Coverage of Acid Indigestion / Heartburn/ Pyrosis Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy:
- Evaluate the marketing status and exclusivity details of Acid Indigestion / Heartburn/ Pyrosis key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Acid Indigestion / Heartburn/ Pyrosis.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Acid Indigestion / Heartburn/ Pyrosis.
- API intelligence over marketed drugs forAcid Indigestion / Heartburn/ Pyrosisand gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Acid Indigestion / Heartburn/ Pyrosis.
- Uncovering opportunities in the rapidly growing US market.

Table Of Contents

Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
Illustrative
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Acid Indigestion / Heartburn/ Pyrosis
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Acid Indigestion / Heartburn/ Pyrosis
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Acid Indigestion / Heartburn/ Pyrosis
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer


List of Tables

- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, US, Marketed Drugs by Application Type, 2017
- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, US, (Year), 2017
- Acid Indigestion / Heartburn/ Pyrosis Marketed Drugs, API Manufacturers by US DMF Status, 2017
- Acid Indigestion / Heartburn/ Pyrosis Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers, Europe by Country, 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers, India by State, 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers, China by Province, 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers by Geography 2017
- Acid Indigestion / Heartburn/ Pyrosis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, Global Sales-2018 (in million USD)
- API Manufacturers for Drug, 2017
- Phase III Drugs for Acid Indigestion / Heartburn/ Pyrosis, 2017
- Discontinued Drugs for Acid Indigestion / Heartburn/ Pyrosis, 2017


List of Figures

- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, US, (Year), 2017
- Acid Indigestion / Heartburn/ Pyrosis Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
- Acid Indigestion / Heartburn/ Pyrosis Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers, Europe by Country, 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers, India by State, 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers, China by Province, 2017
- Acid Indigestion / Heartburn/ Pyrosis Drugs, API Manufacturers by Geography 2017
- Acid Indigestion / Heartburn/ Pyrosis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Acid Indigestion / Heartburn/ Pyrosis Therapeutic Market, Global Sales 2018 (in million USD)
- Drug, Patent/Exclusivity Expiry (Year), 2017

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

This BCC Research report presents a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. Forecast included from 2016 through 2021. ...

Global Proton Pump Inhibitors Market - Growth, Trends, and Forecasts (2016 - 2021)

Global Proton Pump Inhibitors Market - Growth, Trends, and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global proton pump inhibitors market accounted for USD XX million in 2015 and is expected to reach USD XX million in 2016. The market is expected to reach USD XX million by 2021, growing at a CAGR ...

Global Saline Laxative Market Analysis & Trends -Product Type(Milk Of Magnesia, Sodium Phosphate Mono Basic, Fleet Phospho-Soda, Magnesium Hydroxide and Magnesium Citrate), Prescription Type - Forecast to 2025

Global Saline Laxative Market Analysis & Trends -Product Type(Milk Of Magnesia, Sodium Phosphate Mono Basic, Fleet Phospho-Soda, Magnesium Hydroxide and Magnesium Citrate), Prescription Type - Forecast to 2025

  • $ 4200
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Saline Laxative Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include ...


Download Unlimited Documents from Trusted Public Sources

Gastrointestinal Drug Industry in the US

  • January 2017
    15 pages
  • Gastrointestina...  

  • United States  

View report >

Gastrointestinal Drug Industry in India

  • January 2017
    9 pages
  • Gastrointestina...  

    Digestive Syste...  

  • India  

View report >

Gastrointestinal Drug Industry in the US

  • December 2016
    6 pages
  • Gastrointestina...  

  • United States  

    South Korea  

View report >

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.